Annual EBIT
-$22.25 M
-$4.48 M-25.18%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual earnings before interest & taxes is -$22.25 million, with the most recent change of -$4.48 million (-25.18%) on December 31, 2023.
- During the last 3 years, GANX annual EBIT has fallen by -$18.77 million (-539.57%).
- GANX annual EBIT is now -2064.07% below its all-time high of -$1.03 million, reached on December 31, 2018.
Performance
GANX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.46 M
+$3.72 M+45.51%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly earnings before interest & taxes is -$4.46 million, with the most recent change of +$3.72 million (+45.51%) on September 30, 2024.
- Over the past year, GANX quarterly EBIT has dropped by -$51.80 thousand (-1.18%).
- GANX quarterly EBIT is now -770.39% below its all-time high of -$512.30 thousand, reached on March 31, 2020.
Performance
GANX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$21.43 M
+$426.00 K+1.95%
September 30, 2024
Summary
- As of February 12, 2025, GANX TTM earnings before interest & taxes is -$21.43 million, with the most recent change of +$426.00 thousand (+1.95%) on September 30, 2024.
- Over the past year, GANX TTM EBIT has increased by +$826.40 thousand (+3.71%).
- GANX TTM EBIT is now -4082.45% below its all-time high of -$512.30 thousand, reached on March 31, 2020.
Performance
GANX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GANX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.2% | -1.2% | +3.7% |
| 3 y3 years | -539.6% | -39.0% | -55.0% |
| 5 y5 years | -2064.1% | -39.0% | -55.0% |
GANX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -61.0% | at low | -39.0% | +45.5% | -55.0% | +4.4% |
| 5 y | 5-year | -959.6% | at low | -770.4% | +45.5% | -4082.4% | +4.4% |
| alltime | all time | -2064.1% | at low | -770.4% | +45.5% | -4082.4% | +4.4% |
Gain Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.46 M(-45.5%) | -$21.43 M(-1.9%) |
| Jun 2024 | - | -$8.18 M(+86.9%) | -$21.85 M(+2.1%) |
| Mar 2024 | - | -$4.38 M(-0.7%) | -$21.40 M(-3.8%) |
| Dec 2023 | -$22.25 M(+25.2%) | -$4.41 M(-9.8%) | -$22.25 M(-0.7%) |
| Sep 2023 | - | -$4.88 M(-36.8%) | -$22.41 M(+0.6%) |
| Jun 2023 | - | -$7.73 M(+47.8%) | -$22.27 M(+13.0%) |
| Mar 2023 | - | -$5.23 M(+14.7%) | -$19.72 M(+10.9%) |
| Dec 2022 | -$17.78 M(+28.6%) | -$4.56 M(-4.0%) | -$17.78 M(+8.2%) |
| Sep 2022 | - | -$4.75 M(-8.2%) | -$16.42 M(+0.7%) |
| Jun 2022 | - | -$5.18 M(+57.4%) | -$16.31 M(+11.3%) |
| Mar 2022 | - | -$3.29 M | -$14.65 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$13.83 M(+297.4%) | - | - |
| Dec 2021 | - | -$3.21 M(-30.8%) | -$13.83 M(+13.0%) |
| Sep 2021 | - | -$4.64 M(+31.9%) | -$12.23 M(+45.4%) |
| Jun 2021 | - | -$3.51 M(+42.5%) | -$8.42 M(+54.9%) |
| Mar 2021 | - | -$2.47 M(+52.7%) | -$5.43 M(+56.2%) |
| Dec 2020 | -$3.48 M(+65.7%) | - | - |
| Dec 2020 | - | -$1.62 M(+97.2%) | -$3.48 M(+86.7%) |
| Sep 2020 | - | -$819.10 K(+53.8%) | -$1.86 M(+78.4%) |
| Jun 2020 | - | -$532.50 K(+3.9%) | -$1.04 M(+103.9%) |
| Mar 2020 | - | -$512.30 K | -$512.30 K |
| Dec 2019 | -$2.10 M(+104.2%) | - | - |
| Dec 2018 | -$1.03 M | - | - |
FAQ
- What is Gain Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Gain Therapeutics?
- What is Gain Therapeutics annual EBIT year-on-year change?
- What is Gain Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Gain Therapeutics?
- What is Gain Therapeutics quarterly EBIT year-on-year change?
- What is Gain Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Gain Therapeutics?
- What is Gain Therapeutics TTM EBIT year-on-year change?
What is Gain Therapeutics annual earnings before interest & taxes?
The current annual EBIT of GANX is -$22.25 M
What is the all time high annual EBIT for Gain Therapeutics?
Gain Therapeutics all-time high annual earnings before interest & taxes is -$1.03 M
What is Gain Therapeutics annual EBIT year-on-year change?
Over the past year, GANX annual earnings before interest & taxes has changed by -$4.48 M (-25.18%)
What is Gain Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of GANX is -$4.46 M
What is the all time high quarterly EBIT for Gain Therapeutics?
Gain Therapeutics all-time high quarterly earnings before interest & taxes is -$512.30 K
What is Gain Therapeutics quarterly EBIT year-on-year change?
Over the past year, GANX quarterly earnings before interest & taxes has changed by -$51.80 K (-1.18%)
What is Gain Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of GANX is -$21.43 M
What is the all time high TTM EBIT for Gain Therapeutics?
Gain Therapeutics all-time high TTM earnings before interest & taxes is -$512.30 K
What is Gain Therapeutics TTM EBIT year-on-year change?
Over the past year, GANX TTM earnings before interest & taxes has changed by +$826.40 K (+3.71%)